Macromoltek
New accelerator entry · 2017-11-02 · the record
In their words
Macromoltek: Revolutionizing antibody design. Description: Macromoltek, a computational de novo drug design company, rapidly produces accurate and credible antibody designs. We have built a proprietary platform that enables design against difficult targets inaccessible by traditional methods and have are already designing antibodies for large biopharmas and smaller biotechs.
What the record says
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Macromoltek
- Source Check — verify what Macromoltek states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Macromoltek for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist MacromoltekYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Macromoltek: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.